The Enterprise Value as of January 2026 (TTM) for MindMaze Therapeutics Holding S.A. Sponsored ADR (RLFTY) is 25.68M

According to MindMaze Therapeutics Holding S.A. Sponsored ADR’s latest financial reports and current stock price. The company's current Enterprise Value is 25.68M. This represents a change of 32.22% compared to the average of 19.42M of the last 4 quarters.

MindMaze Therapeutics Holding S.A. Sponsored ADR (RLFTY) Historical Enterprise Value (quarterly & annually)

How has RLFTY Enterprise Value performed in the past?

The mean historical Enterprise Value of MindMaze Therapeutics Holding S.A. Sponsored ADR over the last ten years is 106.23M. The current 25.68M Enterprise Value has changed 2.32% with respect to the historical average. Over the past ten years (40 quarters), RLFTY's Enterprise Value was at its highest in in the June 2009 quarter at 8.51T. The Enterprise Value was at its lowest in in the June 2006 quarter at 0.

MindMaze Therapeutics Holding S.A. Sponsored ADR (RLFTY) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of MindMaze Therapeutics Holding S.A. Sponsored ADR Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

MindMaze Therapeutics Holding S.A. Sponsored ADR (RLFTY) Average Enterprise Value

How has RLFTY Enterprise Value performed in the past?

The current Enterprise Value of MindMaze Therapeutics Holding S.A. Sponsored ADR (RLFTY) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

MindMaze Therapeutics Holding S.A. Sponsored ADR (RLFTY) Enterprise Value vs. Peers

How is RLFTY’s Enterprise Value compared to its peers?

MindMaze Therapeutics Holding S.A. Sponsored ADR’s Enterprise Value is less than Helix BioPharma Corp. (174.00M), less than Calliditas Therapeutics AB (publ) (11.24B), greater than PsyBio Therapeutics Corp. (135.91K), less than ZIVO Bioscience, Inc. (41.17M), less than Amplia Therapeutics Limited (37.92M), less than Arch Biopartners Inc. (68.53M), less than Oncotelic Therapeutics, Inc. (47.99M), less than Vext Science, Inc. (83.83M), less than Sernova Corp. (69.21M), less than Vicapsys Life Sciences, Inc. (49.13M),

Build a custom stock screener for MindMaze Therapeutics Holding S.A. Sponsored ADR (RLFTY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like MindMaze Therapeutics Holding S.A. Sponsored ADR using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

MindMaze Therapeutics Holding S.A. Sponsored ADR (RLFTY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like MindMaze Therapeutics Holding S.A. Sponsored ADR or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.